Summit Therapeutics withdraws proposed public offering due to market conditions

Summit Therapeutics Inc.

Effective June 10, 2026, Summit Therapeutics withdrew its previously announced proposed underwritten public offering of securities.
The withdrawal was due to market conditions; no securities were sold in the offering.
The company had not yet priced or completed the offering before termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.